3645 results for «691»

Filter By

3645 results

!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice

20 Nov 2023 – From PCR London Valves 2023

Join this session to navigate through the long-term outcomes of TAVI low-risk trials (Partner 3, Evolut Low Risk...), to enhance your ability to synthesize and interpret clinical evidence and to learn how to seamlessly integrate these insights into your Heart Team's daily clinical practice.

!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice

Mitral TEER - Part 1

20 Nov 2023 – From PCR London Valves 2023

Gain valuable insights into Mitral Transcatheter Edge-to-Edge Repair (TEER) with this session: explore the prognostic impact of post-procedural mitral regurgitation and gradient after TEER for primary mitral regurgitation and delve into the evolving landscape of same-day discharge following transcatheter edge-to-edge repair.

Mitral TEER - Part 1

Rapid-fire - Challenging TAVI procedures - Part 4

20 Nov 2023 – From PCR London Valves 2023

Join this session for insights and innovative solutions to challenging TAVI procedures: explore the dynamics of peri-procedural ST-elevation myocardial infarction during TAVR, witness shifting left ventricular and hemodynamic physiology, unravel a curious case of valve-in-valve TAVR with a crossability challenge, confront the obstructive dilemma of high...

Rapid-fire - Challenging TAVI procedures - Part 4

Challenges in TAVIs, are there guideline recommendations?

20 Nov 2023 – From PCR London Valves 2023

The EAPCI consensus session emphasized the critical role of evaluating and managing coronary artery disease in TAVI candidates, especially in younger and lower-risk patients. Transcatheter heart valve choice influences future coronary access, emphasizing the need for optimized implantation techniques. In cardiogenic shock due to valvular heart...

Challenges in TAVIs, are there guideline recommendations?

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience

18 May 2021

Previous clinical trials suggested that ultra-thin strut biodegradable polymer sirolimus-eluting stent (BP-SES) may be associated with lower target lesion failure (TLF) when compared to durable polymer everolimus-eluting stents (DP-EES). However, the possible underlying mechanisms remain unclear. Therefore, the all-comers CASTLE study was designed to assess the...

Authors :

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience
Didn’t find what you were looking for?